Farney Alan C, Rogers Jeffrey, Orlando Giuseppe, Stratta Robert J
Department of General Surgery, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
Curr Opin Organ Transplant. 2015 Feb;20(1):103-7. doi: 10.1097/MOT.0000000000000147.
Solitary deceased donor kidney and simultaneous pancreas and kidney (SPK) transplantation are the two most common transplant procedures performed for patients with diabetes and uremia, vastly outnumbering all other organ replacement options. Given the improvement in outcomes for solitary pancreas transplantation, the higher mortality for diabetic patients on the waiting list, and the growing shortage of organs (particularly kidneys) for transplantation, the use of living donors for this complex patient population should be more common.
Yet, despite some clear advantages, sequential pancreas after live donor kidney transplant and especially the combined procedure, simultaneous pancreas (from a deceased donor) and living donor kidney transplantation are relatively uncommon.
Possible reasons for the infrequent use of these options and methods for increasing the use of living donor kidneys for the diabetic and uremic patient are presented.
孤立性死亡供体肾移植和胰肾联合移植(SPK)是为糖尿病和尿毒症患者实施的两种最常见的移植手术,其数量远远超过所有其他器官替代选择。鉴于孤立性胰腺移植效果的改善、等待名单上糖尿病患者较高的死亡率以及移植器官(尤其是肾脏)日益短缺的情况,对于这一复杂患者群体使用活体供体的情况应更为普遍。
然而,尽管有一些明显优势,但活体供体肾移植后序贯胰腺移植,尤其是联合手术,即(来自死亡供体的)胰腺与活体供体肾联合移植相对并不常见。
本文介绍了这些选择使用不频繁的可能原因以及增加糖尿病和尿毒症患者活体供体肾使用的方法。